Participants 0 122 3
Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Participants 270 347 8
40 patients with paroxysmal atrial fibrillation (AF) or atrial flutter (AFI).
Participants 431 560 7
20 patients receiving flecainide, 14 of 17 (82%) with AF converted to sinus rhythm, but in 3 patients with AFI flecainide failed.
Participants 565 596 3
patients treated with verapamil
Participants 909 955 3
9 of 15 patients (60%) with AF still converted
Participants 961 1075 4
, 23 of 32 patients (72%) with AF and none of 7 with AFI converted to sinus rhythm after treatment with flecainide
Participants 1289 1324 3
10 patients (26%) after flecainide.
